Anti-HLA/DR, clone HL-39 (Monoclonal) [Mouse]

Anti-HLA/DR, clone HL-39 (Monoclonal) [Mouse]
Item number Size Datasheet Manual SDS Delivery time Quantity Price
MON-MON1082 100 µg - -

14 - 18 business days*

305.00€
 
MON1082 recognizes common epitope on human HLA-DR, which is dependent on the association of the... more
Product information "Anti-HLA/DR, clone HL-39 (Monoclonal) [Mouse]"
MON1082 recognizes common epitope on human HLA-DR, which is dependent on the association of the alpha and beta chains. Recognized epitope is conserved after fixation with glutaraldehyde and formaldehyde. HLA-DR, a member of MHC class II glycoproteins, that bind intracellularly processed peptides and present them to the Th cells, is composed of 36 kDa alpha chain and 27 kDa beta chain, both anchored in the plasma membrane. Together with other MHC II molecules HLA-DR plays a central role in the immune system. Protein function: An alpha chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the beta chain HLA- DRB, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DR-restricted CD4-positive T cells. This guides antigen-specific T- helper effector functions, both antibody-mediated immune response and macrophage activation, to ultimately eliminate the infectious agents and transformed cells (PubMed:29884618, PubMed:17334368, PubMed:8145819, PubMed:15322540, PubMed:22327072, PubMed:27591323, PubMed:31495665, PubMed:15265931, PubMed:9075930, PubMed:24190431). Typically presents extracellular peptide antigens of 10 to 30 amino acids that arise from proteolysis of endocytosed antigens in lysosomes (PubMed:8145819). In the tumor microenvironment, presents antigenic peptides that are primarily generated in tumor-resident APCs likely via phagocytosis of apoptotic tumor cells or macropinocytosis of secreted tumor proteins (PubMed:31495665). Presents peptides derived from intracellular proteins that are trapped in autolysosomes after macroautophagy, a mechanism especially relevant for T cell selection in the thymus and central immune tolerance (PubMed:17182262, PubMed:23783831). The selection of the immunodominant epitopes follows two processing modes: 'bind first, cut/trim later' for pathogen-derived antigenic peptides and 'cut first, bind later' for autoantigens/self- peptides (PubMed:25413013). The anchor residue at position 1 of the peptide N-terminus, usually a large hydrophobic residue, is essential for high affinity interaction with MHCII molecules (PubMed:8145819). [The UniProt Consortium]
Keywords: Anti-HLA-DRA, Anti-HLA-DRA1, Anti-MHC class II antigen DRA, Anti-HLA class II histocompatibility antigen, DR alpha chain, Mouse anti-HLA/DR, clone HL-39 (Monoclonal)
Supplier: MONOSAN
Supplier-Nr: MON1082

Properties

Application: FC, IP
Antibody Type: Monoclonal
Clone: HL-39
Conjugate: No
Host: Mouse
Species reactivity: Human
Immunogen: Raji Burkitt's lymphoma cell line

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-HLA/DR, clone HL-39 (Monoclonal) [Mouse]"
Write a review
or to review a product.
Viewed